$92.36
-0.22-0.24%
Últ. Act.: Oct 16, 7:37 PM
$92.37
-0.21-0.23%
CVS Health (CVS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
CVS Health (CVS) emitió su última guía sobre agosto 5, 2026 para fiscal year 2026. La compañía estimó unas ganancias por acción en el rango de $7.9 - $8.1, en comparación con una estimación de consenso de EPS de $7.44.
En comparación con la previsión anterior, CVS Health elevado redujo su previsión de BPA desde un rango anterior de $7.3 - $7.5.
CVS Health ha emitido 24 actualizaciones de orientación entre el noviembre 2, 2022 y el agosto 5, 2026. During this period, the company raised its outlook 8 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.84 | $2.21 | $0.99 | $1.36 |
| Actual | $2.58 | $2.57 | $1.09 | $1.60 |
| Surprise | +40.2% | +16.3% | +10.1% | +17.6% |
| Revenue | ||||
| Estimate | $100.09B | $94.89B | $103.52B | $98.62B |
| Actual | $106.10B | $100.43B | $105.69B | $102.87B |
| Surprise | +6.00% | +5.84% | +2.10% | +4.31% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.64 | $1.25 | $2.73 | $2.53 |
| Revenue | ||||
| Consensus | $104.85B | $106.99B | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $2.58 | $1.84 | 40.2 % |
| Q1 | May 6, 2026 | $2.57 | $2.21 | 16.3 % |
| Q4 | Feb 10, 2026 | $1.09 | $0.99 | 10.1 % |
| Q3 | Oct 29, 2025 | $1.60 | $1.36 | 17.6 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $106.10B | $100.09B | 6.00 % |
| Q1 | May 6, 2026 | $100.43B | $94.89B | 5.84 % |
| Q4 | Feb 10, 2026 | $105.69B | $103.52B | 2.10 % |
| Q3 | Oct 29, 2025 | $102.87B | $98.62B | 4.31 % |